Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIAS: Tenecteplase in Acute Ischemic Stroke
NCT02101606Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Oct 2009
- Primary completion
- Nov 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tenecteplase in ischemic stroke, sponsored by University of Alberta. Started Oct 2009; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02101606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101606.